Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
Aug 05, 2026
Why Is The New York Times Company (NYT) Stock Down -13.36% Today?

Why Is The New York Times Company (NYT) Stock Down -13.36% Today?

Key Takeaways

  • NYT shares plunged 13.36% to $65.51 during Wednesday's session, following the release of second-quarter 2026 earnings.
  • Primary catalyst: Slower-than-expected digital subscriber growth — 280,000 net additions missed the consensus estimate of approximately 295,300 and decelerated from 310,000 in Q1.
  • Secondary driver: Q3 guidance for digital-only subscription revenue growth of 12% to 15% came in below analyst expectations at the midpoint, signaling a potential moderation in the company's core growth engine.
  • Valuation sensitivity: With a price-to-earnings ratio above 32 prior to the selloff, NYT's premium multiple left virtually no room for even modest disappointments.
  • Earnings beat overshadowed: Revenue of $762.5 million and adjusted EPS of $0.69 both topped Wall Street forecasts, but the subscriber miss and cautious outlook dominated market reaction.
  • What to watch: Traders are now focused on whether subscriber momentum can recover in the back half of 2026 and how video investments contribute to long-term growth.

Opening Summary

Shares of NYT, the parent company of The New York Times — the 175-year-old media organization behind its flagship newspaper, digital journalism platforms, The Athletic, Wirecutter, and games including Wordle — tumbled 13.36% on Wednesday. The stock fell to $65.51 intraday from a prior close of $75.61, as investors reacted sharply to second-quarter results that, despite beating on both the top and bottom lines, revealed a meaningful slowdown in digital subscriber growth and a forward outlook that fell short of expectations.

Q2 Earnings: A Beat That Wasn't Enough

At first glance, the numbers looked solid. The New York Times Company reported total revenue of $762.5 million, up 11.2% year-over-year and ahead of the $752.3 million consensus. Adjusted earnings per share came in at $0.69, surpassing the $0.67 analysts had projected. Digital advertising revenue surged 20.7% to $114 million, while total advertising revenue climbed 11.3% to $149.1 million, beating estimates. CEO Meredith Kopit Levien called it "another strong quarter" driven by "consistent execution of our strategy."

Yet the market focused squarely on what went wrong. The company added 280,000 net digital-only subscribers during the quarter, missing the Visible Alpha consensus of approximately 295,300. That figure also marked a deceleration from the 310,000 digital-only subscribers added in the first quarter. With total subscribers reaching 13.35 million, the growth trajectory that has long underpinned NYT's premium valuation showed its first signs of fatigue.

Subscriber Growth Miss Ratles Confidence

The subscriber miss struck at the heart of the investment thesis for NYT. For years, the company's ability to consistently add hundreds of thousands of digital subscribers each quarter has been the primary driver of its stock's outperformance. The sequential slowdown — from 310,000 additions in Q1 to 280,000 in Q2 — raised questions about whether the company is approaching a saturation point in its addressable market, even as it continues bundling news with lifestyle products such as The Athletic, Wirecutter, and games.

Competition in the digital media landscape is intensifying. Outlets including Axios, CNN, and The Verge are battling for reader attention, while major technology platforms and AI-powered tools continue to siphon referral traffic away from traditional publishers. The company acknowledged these headwinds, noting that "big tech firms and AI platforms impact search and referral traffic, while trust in news is shrinking." Management emphasized that the Times is not immune to these trends, though it is building resilience through direct audience relationships and app-based engagement.

Guidance Disappointment Compounds the Selloff

Adding fuel to the selloff was the company's third-quarter outlook. NYT guided for digital-only subscription revenue growth of 12% to 15% in Q3, with the midpoint falling below the consensus estimate of 14.2%. Total subscription revenue is expected to grow 9% to 11%, a step down from the 11.2% pace delivered in Q2. For a stock trading at a premium multiple, any signal of decelerating growth was enough to trigger a sharp re-rating.

Operating costs also drew scrutiny, rising 10% in Q2 versus the company's own guidance range of 8% to 9%. The overage was attributed primarily to variable compensation tied to financial outperformance and higher marketing investments, including promotional activity around the World Cup. Free cash flow margin contracted notably to 1.3% from 15.1% a year earlier, though the company noted that some of the decline reflected timing of seasonal working capital that is expected to reverse in the second half.

Market Context and Trading Activity

The selloff in NYT was entirely company-specific, with the broader market providing no cover. The S&P 500, Dow Jones Industrial Average, and Nasdaq all traded modestly higher during the session, underscoring that the pressure on NYT was driven by its own fundamentals rather than macro headwinds. Trading volume was significantly elevated relative to the stock's average, reflecting the intensity of the post-earnings repositioning by institutional and retail investors alike. The decline pushed shares decisively below key technical levels, including the 50-day moving average, and brought the stock closer to its 52-week range's lower bound.

What Comes Next for NYT

The road ahead for NYT hinges on whether the company can reaccelerate subscriber growth in the second half of 2026. Management remains confident in its "path to achieving midterm targets for subscribers, AOP growth, and capital returns," and has pointed to video as a key long-term growth vector. The company is now producing thousands of original videos each quarter and recently launched a Shows tab in its flagship app to deepen engagement. However, video monetization remains in early stages and is not yet a meaningful contributor to advertising revenue.

Risks include increasingly tough year-over-year comparisons, particularly in advertising supply growth, and the ongoing structural decline in third-party referral traffic from search and social platforms. The company's ability to convert its substantial audience into paying subscribers at higher price points will be a critical metric for investors in the quarters ahead. With analysts maintaining a consensus Hold rating and a median price target that had already been below the pre-earnings share price, sentiment was cautious even before Wednesday's report.

Trending AI Robots

For traders looking to navigate volatile earnings-driven moves like the one in NYT, Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots designed to adapt to shifting market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers across multiple strategies, timeframes, and performance metrics, but only the strongest performers under current market conditions are featured in this curated section. Whether you are focused on momentum, swing trading, or longer-term trend following, the Trending AI Robots page provides a practical starting point for identifying systematic strategies that are delivering results right now.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: NYT

NYT's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for NYT turned positive on July 29, 2026. Looking at past instances where NYT's MACD turned positive, the stock continued to rise in of 50 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 03, 2026. You may want to consider a long position or call options on NYT as a result. In of 82 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

NYT moved above its 50-day moving average on July 28, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for NYT crossed bullishly above the 50-day moving average on July 17, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where NYT advanced for three days, in of 336 cases, the price rose further within the following month. The odds of a continued upward trend are .

NYT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 249 cases where NYT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 60 cases where NYT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NYT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NYT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.116) is normal, around the industry mean (6.348). P/E Ratio (32.451) is within average values for comparable stocks, (22.557). NYT's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (2.008). NYT has a moderately low Dividend Yield (0.011) as compared to the industry average of (0.020). NYT's P/S Ratio (4.290) is very high in comparison to the industry average of (1.490).

Industry description

The newspaper publishing industry includes companies that publish and market news journals and daily/weekly newspapers. News Corporation, New York Times Company, and Gannett Co., Inc. are some of the largest newspaper publishers. Commercial ad revenue helps to cover plant and equipment costs and general and administrative expense. The popularity and distribution network of newspaper publishers could affect the fees they can charge on advertisements. In recent decades, with digital content grabbing advertising dollars, long-standing publishing companies have increasingly diversified into creating their own web-based content to stay in business.

Market Cap

The average market capitalization across the Publishing: Newspapers Industry is 3.78B. The market cap for tickers in the group ranges from 11.31K to 13.62B. IFPJF holds the highest valuation in this group at 13.62B. The lowest valued company is XLMDF at 11.31K.

High and low price notable news

The average weekly price growth across all stocks in the Publishing: Newspapers Industry was -1%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 44%. SCHL experienced the highest price growth at 7%, while PSO experienced the biggest fall at -5%.

Volume

The average weekly volume growth across all stocks in the Publishing: Newspapers Industry was 56%. For the same stocks of the Industry, the average monthly volume growth was 71% and the average quarterly volume growth was -15%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 42
P/E Growth Rating: 48
Price Growth Rating: 49
SMR Rating: 67
Profit Risk Rating: 77
Seasonality Score: -40 (-100 ... +100)
View a ticker or compare two or three
NYT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a global, multimedia news and information company, which engages in publishing newspapers, digital businesses, investments in paper mills and other investments

Industry PublishingNewspapers

Profile
Details
Industry
Publishing Newspapers
Address
620 Eighth Avenue
Phone
+1 212 556-1234
Employees
5900
Web
https://www.nytco.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.